Cetuximab sarotalocan (Cetuximab-IRDye-700DX) is an IRdye700DX (near-infrared photosensitizing dye) conjugate of Cetuximab (anti-EGFRmonoclonal antibody). Cetuximab sarotalocan can be used for head and neck cancers research^[1][2].

Cetuximab sarotalocan sodium is formed by an antibody-photosensitive complex that combines Cetuximab, an epidermal growth factor receptor monoclonal antibody, with the dye IRdye700DX, a photosensitive substance. After administration of Cetuximab sarotalocan sodium, only tumor cells are specifically destroyed by illumination with a red light at 690 nm^[2].

2166339-33-7

Please store the product under the recommended conditions in the Certificate of Analysis.